{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:40:08Z","timestamp":1793241608069,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13555-021-00536-6","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T08:02:59Z","timestamp":1619683379000},"page":"833-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Genital and Inverse\/Intertriginous Psoriasis: An Updated Review of Therapies and Recommendations for Practical Management"],"prefix":"10.1007","volume":"11","author":[{"given":"Julie J.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Hadeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Brownstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson J.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"issue":"6","key":"536_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/reum.2018.80718","volume":"56","author":"K Dopytalska","year":"2018","unstructured":"Dopytalska K, Sobolewski P, B\u0142aszczak A, Szyma\u0144ska E, Walecka I. Psoriasis in special localizations. Reumatologia. 2018;56(6):392\u20138. https:\/\/doi.org\/10.5114\/reum.2018.80718.","journal-title":"Reumatologia"},{"key":"536_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/PTT.S169389","volume":"8","author":"EJ Yang","year":"2018","unstructured":"Yang EJ, Beck KM, Sanchez IM, Koo J, Liao W. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis Auckl NZ. 2018;8:41\u20137. https:\/\/doi.org\/10.2147\/PTT.S169389.","journal-title":"Psoriasis Auckl NZ"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/PTT.S159916","volume":"8","author":"GV Duarte","year":"2018","unstructured":"Duarte GV, Calmon H, Radel G, de F\u00e1tima Paim OM. Psoriasis and sexual dysfunction: links, risks, and management challenges. Psoriasis Auckl NZ. 2018;8:93\u20139. https:\/\/doi.org\/10.2147\/PTT.S159916.","journal-title":"Psoriasis Auckl NZ."},{"issue":"8","key":"536_CR4","first-page":"793","volume":"16","author":"JF Merola","year":"2017","unstructured":"Merola JF, Bleakman AP, Gottlieb AB, et\u00a0al. The Static Physician\u2019s Global Assessment of Genitalia: a clinical outcome measure for the severity of genital psoriasis. J Drugs Dermatol JDD. 2017;16(8):793\u20139.","journal-title":"J Drugs Dermatol JDD"},{"issue":"1","key":"536_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13555-017-0213-2","volume":"8","author":"AB Gottlieb","year":"2018","unstructured":"Gottlieb AB, Kirby B, Ryan C, et\u00a0al. The development of a patient-reported outcome measure for assessment of genital psoriasis symptoms: the Genital Psoriasis Symptoms Scale (GPSS). Dermatol Ther. 2018;8(1):45\u201356. https:\/\/doi.org\/10.1007\/s13555-017-0213-2.","journal-title":"Dermatol Ther"},{"issue":"4","key":"536_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.0105-1873.2004.00444.x","volume":"51","author":"M Farage","year":"2004","unstructured":"Farage M, Maibach HI. The vulvar epithelium differs from the skin: implications for cutaneous testing to address topical vulvar exposures. Contact Dermatitis. 2004;51(4):201\u20139. https:\/\/doi.org\/10.1111\/j.0105-1873.2004.00444.x.","journal-title":"Contact Dermatitis"},{"issue":"4","key":"536_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s13555-018-0257-y","volume":"8","author":"KM Beck","year":"2018","unstructured":"Beck KM, Yang EJ, Sanchez IM, Liao W. Treatment of genital psoriasis: a systematic review. Dermatol Ther. 2018;8(4):509\u201325. https:\/\/doi.org\/10.1007\/s13555-018-0257-y.","journal-title":"Dermatol Ther"},{"issue":"8","key":"536_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/09546634.2019.1620912","volume":"31","author":"KA Reynolds","year":"2020","unstructured":"Reynolds KA, Pithadia DJ, Lee EB, Wu JJ. Treatments for inverse psoriasis: a systematic review. J Dermatol Treat. 2020;31(8):786\u201393. https:\/\/doi.org\/10.1080\/09546634.2019.1620912.","journal-title":"J Dermatol Treat"},{"issue":"3","key":"536_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","volume":"61","author":"A Menter","year":"2009","unstructured":"Menter A, Korman NJ, Elmets CA, et\u00a0al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451\u201385. https:\/\/doi.org\/10.1016\/j.jaad.2009.03.027.","journal-title":"J Am Acad Dermatol."},{"issue":"8","key":"536_CR10","first-page":"760","volume":"16","author":"H Khosravi","year":"2017","unstructured":"Khosravi H, Siegel MP, Van Voorhees AS, Merola JF. Treatment of inverse\/intertriginous psoriasis: updated guidelines from the Medical Board of the National Psoriasis Foundation. J Drugs Dermatol JDD. 2017;16(8):760\u20136.","journal-title":"J Drugs Dermatol JDD"},{"issue":"1","key":"536_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1067\/mjd.2001.110046","volume":"44","author":"MG Lebwohl","year":"2001","unstructured":"Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol. 2001;44(1):77\u201382. https:\/\/doi.org\/10.1067\/mjd.2001.110046.","journal-title":"J Am Acad Dermatol."},{"issue":"2","key":"536_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3928\/0090-4481-20060201-06","volume":"35","author":"M Greco","year":"2006","unstructured":"Greco M, Chamlin SL. An 18-month-old girl with chronic diaper dermatitis. Psoriasis presenting in the diaper area. Pediatr Ann. 2006;35(2):79\u201383. https:\/\/doi.org\/10.3928\/0090-4481-20060201-06.","journal-title":"Pediatr Ann."},{"issue":"4","key":"536_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/LGT.0b013e31824b9e5e","volume":"16","author":"S Kapila","year":"2012","unstructured":"Kapila S, Bradford J, Fischer G. Vulvar psoriasis in adults and children: a clinical audit of 194 cases and review of the literature. J Low Genit Tract Dis. 2012;16(4):364\u201371. https:\/\/doi.org\/10.1097\/LGT.0b013e31824b9e5e.","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"536_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2340\/00015555-1885","volume":"95","author":"KAP Meeuwis","year":"2015","unstructured":"Meeuwis KAP, de Hullu JA, IntHout J, et\u00a0al. Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis. Acta Derm Venereol. 2015;95(2):211\u20136. https:\/\/doi.org\/10.2340\/00015555-1885.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"536_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.clindermatol.2007.10.026","volume":"26","author":"G Wozel","year":"2008","unstructured":"Wozel G. Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas. Clin Dermatol. 2008;26(5):448\u201359. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.10.026.","journal-title":"Clin Dermatol"},{"issue":"9","key":"536_CR16","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1001\/archderm.142.9.1138","volume":"142","author":"A Kreuter","year":"2006","unstructured":"Kreuter A, Sommer A, Hyun J, et\u00a0al. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. Arch Dermatol. 2006;142(9):1138\u201343. https:\/\/doi.org\/10.1001\/archderm.142.9.1138.","journal-title":"Arch Dermatol."},{"issue":"5","key":"536_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1365-2133.2006.07423.x","volume":"155","author":"N Foureur","year":"2006","unstructured":"Foureur N, Vanzo B, Meaume S, Senet P. Prospective aetiological study of diaper dermatitis in the elderly. Br J Dermatol. 2006;155(5):941\u20136. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07423.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"536_CR18","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jpag.2014.10.007","volume":"28","author":"M Hernandez","year":"2015","unstructured":"Hernandez M, Simms-Cendan J, Zendell K. Guttate psoriasis following streptococcal vulvovaginitis in a five-year-old girl. J Pediatr Adolesc Gynecol. 2015;28(5):e127-129. https:\/\/doi.org\/10.1016\/j.jpag.2014.10.007.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"536_CR19","unstructured":"LEO PHARMA AS. PROTOPIC (tacrolimus). 2006."},{"issue":"3","key":"536_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1747.1998.00323.x","volume":"111","author":"S Reitamo","year":"1998","unstructured":"Reitamo S, Rissanen J, Remitz A, et\u00a0al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol. 1998;111(3):396\u20138. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00323.x.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"536_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","volume":"51","author":"M Lebwohl","year":"2004","unstructured":"Lebwohl M, Freeman AK, Chapman MS, et\u00a0al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004;51(5):723\u201330. https:\/\/doi.org\/10.1016\/j.jaad.2004.07.011.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"536_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","volume":"51","author":"C Gribetz","year":"2004","unstructured":"Gribetz C, Ling M, Lebwohl M, et\u00a0al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004;51(5):731\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2004.06.010.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"536_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","volume":"80","author":"CA Elmets","year":"2019","unstructured":"Elmets CA, Leonardi CL, Davis DMR, et\u00a0al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019;80(4):1073\u2013113. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.058.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"536_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","volume":"148","author":"JP Ortonne","year":"2003","unstructured":"Ortonne JP, Humbert P, Nicolas JF, et\u00a0al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol. 2003;148(2):326\u201333. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05228.x.","journal-title":"Br J Dermatol"},{"issue":"5","key":"536_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","volume":"157","author":"YH Liao","year":"2007","unstructured":"Liao YH, Chiu HC, Tseng YS, Tsai TF. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br J Dermatol. 2007;157(5):1005\u201312. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08201.x.","journal-title":"Br J Dermatol."},{"issue":"3","key":"536_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4161\/derm.3.3.17534","volume":"3","author":"L Tr\u00e9mezaygues","year":"2011","unstructured":"Tr\u00e9mezaygues L, Reichrath J. Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going? Dermatoendocrinol. 2011;3(3):180\u20136. https:\/\/doi.org\/10.4161\/derm.3.3.17534.","journal-title":"Dermatoendocrinol"},{"issue":"Suppl 2","key":"536_CR27","doi-asserted-by":"publisher","first-page":"ii83","DOI":"10.1136\/ard.2004.030791","volume":"64","author":"M Lebwohl","year":"2005","unstructured":"Lebwohl M, Ting PT, Koo JYM. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005;64(Suppl 2):ii83\u20136. https:\/\/doi.org\/10.1136\/ard.2004.030791.","journal-title":"Ann Rheum Dis."},{"issue":"19","key":"536_CR28","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.febslet.2012.07.058","volume":"586","author":"YR Freund","year":"2012","unstructured":"Freund YR, Akama T, Alley MRK, et\u00a0al. Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett. 2012;586(19):3410\u20134. https:\/\/doi.org\/10.1016\/j.febslet.2012.07.058.","journal-title":"FEBS Lett"},{"issue":"11","key":"536_CR29","first-page":"1236","volume":"10","author":"R Nazarian","year":"2009","unstructured":"Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs Lond Engl 2000. 2009;10(11):1236\u201342.","journal-title":"Curr Opin Investig Drugs Lond Engl 2000."},{"issue":"5","key":"536_CR30","doi-asserted-by":"crossref","first-page":"22608","DOI":"10.5070\/D3205022608","volume":"20","author":"F Moustafa","year":"2014","unstructured":"Moustafa F, Feldman SR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014;20(5):22608.","journal-title":"Dermatol Online J"},{"issue":"5","key":"536_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40257-016-0204-6","volume":"17","author":"LT Zane","year":"2016","unstructured":"Zane LT, Hughes MH, Shakib S. Tolerability of crisaborole ointment for application on sensitive skin areas: a randomized, double-blind, vehicle-controlled study in healthy volunteers. Am J Clin Dermatol. 2016;17(5):519\u201326. https:\/\/doi.org\/10.1007\/s40257-016-0204-6.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"536_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaad.2019.06.1288","volume":"82","author":"PW Hashim","year":"2020","unstructured":"Hashim PW, Chima M, Kim HJ, et\u00a0al. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial. J Am Acad Dermatol. 2020;82(2):360\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1288.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"536_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa2000073","volume":"383","author":"MG Lebwohl","year":"2020","unstructured":"Lebwohl MG, Papp KA, Stein Gold L, et\u00a0al. Trial of roflumilast cream for chronic plaque psoriasis. N Engl J Med. 2020;383(3):229\u201339. https:\/\/doi.org\/10.1056\/NEJMoa2000073.","journal-title":"N Engl J Med"},{"issue":"8","key":"536_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1046\/j.1365-2230.2000.00710.x","volume":"25","author":"CH Smith","year":"2000","unstructured":"Smith CH, Jackson K, Chinn S, Angus K, Barker JN. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis. Clin Exp Dermatol. 2000;25(8):580\u20133. https:\/\/doi.org\/10.1046\/j.1365-2230.2000.00710.x.","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"536_CR35","first-page":"37","volume":"3","author":"JA Zeichner","year":"2010","unstructured":"Zeichner JA. Use of topical coal tar foam for the treatment of psoriasis in difficult-to-treat areas. J Clin Aesthetic Dermatol. 2010;3(9):37\u201340.","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"1","key":"536_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaad.2008.06.041","volume":"60","author":"RE Kalb","year":"2009","unstructured":"Kalb RE, Bagel J, Korman NJ, et\u00a0al. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009;60(1):120\u20134. https:\/\/doi.org\/10.1016\/j.jaad.2008.06.041.","journal-title":"J Am Acad Dermatol"},{"key":"536_CR37","first-page":"72","volume":"146","author":"EW Rosenberg","year":"1989","unstructured":"Rosenberg EW, Noah PW, Skinner RB, Vander Zwaag R, West SK, Browder JF. Microbial associations of 167 patients with psoriasis. Acta Derm Venereol Suppl (Stockh). 1989;146:72\u20134 (discussion 75).","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"issue":"6","key":"536_CR38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1046\/j.1525-1470.2002.00236_1.x","volume":"19","author":"M Watanabe","year":"2002","unstructured":"Watanabe M, Tabata N, Tagami H. Explosive diaper pustular psoriasis. Pediatr Dermatol. 2002;19(6):564\u20135. https:\/\/doi.org\/10.1046\/j.1525-1470.2002.00236_1.x.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"536_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","volume":"82","author":"B Strober","year":"2020","unstructured":"Strober B, Ryan C, van de Kerkhof P, et\u00a0al. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council. J Am Acad Dermatol. 2020;82(1):117\u201322. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.026.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"536_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/ccr3.2759","volume":"8","author":"M Tajalli","year":"2020","unstructured":"Tajalli M, Kabir S, Vance TM, Qureshi AA. Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis. Clin Case Rep. 2020;8(5):819\u201322. https:\/\/doi.org\/10.1002\/ccr3.2759.","journal-title":"Clin Case Rep"},{"issue":"4","key":"536_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, Strassner JP, Refat MA, Harris JE, King BA. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol. 2017;77(4):675-682.e1. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.043.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"536_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bjd.17149","volume":"180","author":"BE Strober","year":"2019","unstructured":"Strober BE, Gottlieb AB, van de Kerkhof PCM, et\u00a0al. Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials. Br J Dermatol. 2019;180(1):67\u201375. https:\/\/doi.org\/10.1111\/bjd.17149.","journal-title":"Br J Dermatol"},{"issue":"3","key":"536_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-4362.1996.tb01641.x","volume":"35","author":"MB Quan","year":"1996","unstructured":"Quan MB, Ruben BS. Pustular psoriasis limited to the penis. Int J Dermatol. 1996;35(3):202\u20134. https:\/\/doi.org\/10.1111\/j.1365-4362.1996.tb01641.x.","journal-title":"Int J Dermatol"},{"issue":"4","key":"536_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4103\/0378-6323.42920","volume":"74","author":"N Singh","year":"2008","unstructured":"Singh N, Thappa DM. Circinate pustular psoriasis localized to glans penis mimicking \u201ccircinate balanitis\u201d and responsive to dapsone. Indian J Dermatol Venereol Leprol. 2008;74(4):388\u20139.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"536_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13555-012-0015-5","volume":"2","author":"A Guglielmetti","year":"2012","unstructured":"Guglielmetti A, Conlledo R, Bedoya J, Ianiszewski F, Correa J. Inverse psoriasis involving genital skin folds: successful therapy with dapsone. Dermatol Ther. 2012;2(1):15. https:\/\/doi.org\/10.1007\/s13555-012-0015-5.","journal-title":"Dermatol Ther"},{"key":"536_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-3-662-44605-8_18","volume":"226","author":"TA Leslie","year":"2015","unstructured":"Leslie TA, Greaves MW, Yosipovitch G. Current topical and systemic therapies for itch. Handb Exp Pharmacol. 2015;226:337\u201356. https:\/\/doi.org\/10.1007\/978-3-662-44605-8_18.","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"536_CR47","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2230.2004.01505.x","volume":"29","author":"S Albert","year":"2004","unstructured":"Albert S, Neill S, Derrick EK, Calonje E. Psoriasis associated with vulval scarring. Clin Exp Dermatol. 2004;29(4):354\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01505.x.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"536_CR48","first-page":"439","volume":"45","author":"Y Shimamoto","year":"1990","unstructured":"Shimamoto Y, Shimamoto H. Annular pustular psoriasis associated with affective psychosis. Cutis. 1990;45(6):439\u201342.","journal-title":"Cutis"},{"issue":"11","key":"536_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.jsxm.2018.09.004","volume":"15","author":"G Yosipovitch","year":"2018","unstructured":"Yosipovitch G, Foley P, Ryan C, et\u00a0al. Ixekizumab improved patient-reported genital psoriasis symptoms and impact of symptoms on sexual activity vs placebo in a randomized double-blind study. J Sex Med. 2018;15(11):1645\u201352. https:\/\/doi.org\/10.1016\/j.jsxm.2018.09.004.","journal-title":"J Sex Med"},{"issue":"4","key":"536_CR50","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bjd.16736","volume":"179","author":"C Ryan","year":"2018","unstructured":"Ryan C, Menter A, Guenther L, et\u00a0al. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis. Br J Dermatol. 2018;179(4):844\u201352. https:\/\/doi.org\/10.1111\/bjd.16736.","journal-title":"Br J Dermatol"},{"issue":"1","key":"536_CR51","doi-asserted-by":"publisher","first-page":"adv00006","DOI":"10.2340\/00015555-3353","volume":"100","author":"L Guenther","year":"2020","unstructured":"Guenther L, Potts Bleakman A, Weisman J, et\u00a0al. Ixekizumab results in persistent clinical improvement in moderate-to-severe genital psoriasis during a 52 week, randomized, placebo-controlled, phase 3 clinical trial. Acta Derm Venereol. 2020;100(1):adv00006. https:\/\/doi.org\/10.2340\/00015555-3353.","journal-title":"Acta Derm Venereol."},{"issue":"1","key":"536_CR52","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1111\/dth.13110","volume":"33","author":"M Burlando","year":"2020","unstructured":"Burlando M, Herzum A, Carmisciano L, Cozzani E, Parodi A. Biological therapy in genital psoriasis in women. Dermatol Ther. 2020;33(1):e13110. https:\/\/doi.org\/10.1111\/dth.13110.","journal-title":"Dermatol Ther"},{"key":"536_CR53","doi-asserted-by":"crossref","unstructured":"LILLY. Ixekizumab (Taltz). 2016.","DOI":"10.12968\/eqhe.2016.30.22"},{"issue":"1","key":"536_CR54","first-page":"21","volume":"23","author":"R Je\u0161e","year":"2014","unstructured":"Je\u0161e R, Perdan-Pirkmajer K, Dolenc-Volj\u010d M, Tom\u0161i\u010d M. A case of inverse psoriasis successfully treated with adalimumab. Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(1):21\u20133.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"536_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215019","author":"MA Campos","year":"2016","unstructured":"Campos MA, Varela P, Baptista A, Moreira AI. Inverse psoriasis treated with ustekinumab. BMJ Case Rep. 2016. https:\/\/doi.org\/10.1136\/bcr-2016-215019.","journal-title":"BMJ Case Rep."},{"issue":"4","key":"536_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/pho.2008.2317","volume":"27","author":"SP Nistic\u00f2","year":"2009","unstructured":"Nistic\u00f2 SP, Saraceno R, Schipani C, Costanzo A, Chimenti S. Different applications of monochromatic excimer light in skin diseases. Photomed Laser Surg. 2009;27(4):647\u201354. https:\/\/doi.org\/10.1089\/pho.2008.2317.","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"536_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1468-3083.2007.02457.x","volume":"22","author":"M Zanchi","year":"2008","unstructured":"Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P. Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol JEADV. 2008;22(4):431\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02457.x.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"536_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.181","author":"LS Gold","year":"2020","unstructured":"Gold LS, Bhatia N, Tallman AM, Rubenstein DS. A phase IIb, randomized clinical trial of tapinarof cream for the treatment of plaque psoriasis: secondary efficacy and patient-reported outcomes. J Am Acad Dermatol. 2020. https:\/\/doi.org\/10.1016\/j.jaad.2020.04.181.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"536_CR59","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jaad.2018.10.037","volume":"80","author":"K Robbins","year":"2019","unstructured":"Robbins K, Bissonnette R, Maeda-Chubachi T, et\u00a0al. Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis. J Am Acad Dermatol. 2019;80(3):714\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2018.10.037.","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"536_CR60","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.1021\/acs.jmedchem.0c00450","volume":"63","author":"S Noji","year":"2020","unstructured":"Noji S, Hara Y, Miura T, et\u00a0al. Discovery of a Janus kinase inhibitor bearing a highly three-dimensional Spiro scaffold: JTE-052 (delgocitinib) as a new dermatological agent to treat inflammatory skin disorders. J Med Chem. 2020;63(13):7163\u201385. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00450.","journal-title":"J Med Chem"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00536-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00536-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T21:27:41Z","timestamp":1672003661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00536-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00536-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"18 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}